Effect of the ostreolysin A/pleurotolysin B pore-forming complex on intracellular Ca2+ activity in the vascular smooth muscle cell line A10

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Milka VreclR Frangez

Abstract

Ostreolysin A/pleurotolysin B (OlyA/PlyB) is a binary pore-forming protein complex that produces a rapid cardiorespiratory arrest. Increased tonus of the coronary vascular wall produced by OlyA/PlyB may lead to ischemia, arrhythmias, the hypoxic injury of cardiomyocytes and cardiotoxicity. We evaluated the effects of OlyA/PlyB in cultured vascular smooth muscle A10 cells. Fluorometric measurements using the Ca(2+) indicator Fluo-4 AM and Fura-2 AM revealed that nanomolar concentrations of OlyA/PlyB increased the intracellular Ca(2+) activity [Ca(2+)]i in A10 cells. This effect was absent in a Ca(2+)-free medium, indicating that OlyA/PlyB-induced [Ca(2+)]i increase was dependent on Ca(2+) influx into cells. The increase in [Ca(2+)]i by OlyA/PlyB was partially prevented by: i) the calcium channel blockers verapamil and La(3+), ii) the inhibitor of the sodium-calcium exchanger (NCX) benzamil, and iii) the iso-osmotic replacement of NaCl by sucrose. The pre-treatment of cells with the Ca(2+)-ATPase inhibitor thapsigargin reduced the [Ca(2+)]i increase evoked by OlyA/PlyB, whereas the plasma membrane depolarization with high K(+) in the medium did not prevent OlyA/PlyB-induced [Ca(2+)]i. In summary, our data could suggest that the O...Continue Reading

References

Mar 15, 1976·Experimental Cell Research·B W Kimes, B L Brandt
Jan 1, 1992·Pflügers Archiv : European journal of physiology·I Baró, D A Eisner
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·O ThastrupA P Dawson
Dec 1, 1985·Pflügers Archiv : European journal of physiology·M F Wendt-Gallitelli, G Isenberg
Feb 28, 1985·Biochemical and Biophysical Research Communications·S KongsamutR J Miller
Dec 1, 1987·Journal of Ethnopharmacology·I H Al-DeenT A Istarabadi
Jan 1, 1996·British Journal of Pharmacology·Y T Xuan, P S Glass
Oct 7, 2000·Stroke; a Journal of Cerebral Circulation·V NazarovM Apkon
Apr 15, 2006·Circulation Research·Brian R WamhoffGary K Owens
Jul 25, 2006·Toxicon : Official Journal of the International Society on Toxinology·Monika Cecilija ZuzekRobert Frangez
Mar 14, 2007·Toxicon : Official Journal of the International Society on Toxinology·Katja ReboljRobert Frangez
Mar 25, 2009·Protein Science : a Publication of the Protein Society·Sabina BerneKristina Sepcić
Jun 16, 2009·Toxicon : Official Journal of the International Society on Toxinology·Polona JuntesRobert Frangez
Jul 3, 2010·Cell Death and Differentiation·E B BabiychukA Draeger
Sep 3, 2011·The Journal of Biological Chemistry·Ana J García-SáezPetra Schwille
Feb 7, 2013·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Gregory C Amberg, Manuel F Navedo
Jan 4, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Milka VreclRobert Frangež

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.